News Novo enjoys strong Q1 as Trump price crackdown fails to mate... Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results.
News Novo completes major filings for blockbuster hope semaglutid... Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.
Views & Analysis Pharma marketing requires a global approach The industry must update its strategy for the digital age.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News Dire warnings of decline in pharma productivity Deloitte report makes grim reading for those in R&D.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends